Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Pension (2023 - 2025)

Monte Rosa Therapeutics (GLUE) has 3 years of Pension data on record, last reported at $4.7 million in Q3 2025.

  • For Q3 2025, Pension rose 67.91% year-over-year to $4.7 million; the TTM value through Sep 2025 reached $4.7 million, up 67.91%, while the annual FY2024 figure was $3.7 million, 36.45% up from the prior year.
  • Pension reached $4.7 million in Q3 2025 per GLUE's latest filing, up from $4.6 million in the prior quarter.
  • Across five years, Pension topped out at $4.7 million in Q3 2025 and bottomed at $1.5 million in Q3 2023.
  • Average Pension over 3 years is $2.9 million, with a median of $2.7 million recorded in 2023.
  • The widest YoY moves for Pension: up 94.29% in 2024, down 36.45% in 2024.
  • A 3-year view of Pension shows it stood at $2.7 million in 2023, then soared by 36.45% to $3.7 million in 2024, then increased by 28.04% to $4.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Pension were $4.7 million in Q3 2025, $4.6 million in Q2 2025, and $4.0 million in Q1 2025.